Home / Coagulation Factor IX / Switzerland
CH ATC B02BD04 · updated 2 Nov 2026
Coagulation Factor IX shortage in Switzerland
Is there a Coagulation Factor IX shortage in Switzerland?
Yes. As of 2 Nov 2026, 2 Coagulation Factor IX products are reported short in Switzerland, the first since 1 Jan 2026. The company estimate for the return is 31 Dec 2026. Main reason: not stated.
Also short in Spain, Sweden. All countries.
Affected products in Switzerland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CH | REFIXIA Trockensub 1000 IE c Solv Durchstf | Novo Nordisk Pharma AG | 1 Jan 2026 | 31 Dec 2026 | Not stated |
| CH | REFIXIA Trockensub 2000 IE c Solv Durchstf | Novo Nordisk Pharma AG | 1 Jan 2026 | 31 Dec 2026 | Not stated |
Source
FONES (Federal Office for National Economic Supply), reporting office for vital medicines. Official list. Vital human medicines only (the federal list of reportable active substances); one row per pack (GTIN).